Search results
CMDHD launches new hepatitis C treatment program
Midland Daily News· 1 hour agoCentral Michigan District Health Department launched a new hepatitis C treatment program, aimed at providing accessible and effective treatment to individuals ...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 4 days agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
The ultimate guide to travel vaccinations
The Telegraph via Yahoo News· 1 hour agoWherever your travels take you, whatever the purpose of your trip, finding out about likely health risks at your destination – and how to reduce them –...
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
FierceBiotech· 5 days agoVir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase...
More rare cancers being diagnosed after the pandemic
Becker’s Hospital Review· 4 days agoIt's possible that COVID-19 could be another infection that promotes cancer, but conclusive answers are not yet available. "We are completely under-investigating this virus
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 4 days agoThis study has already achieved its primary endpoint – NASH patients who received VK2809 achieved a...
Arbutus Biopharma (NASDAQ:ABUS) Rating Reiterated by Chardan Capital
ETF DAILY NEWS· 5 days agoChardan Capital reissued their buy rating on shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) in a research note released on Wednesday, Benzinga reports. The firm currently ...
Unregulated and unlicensed skincare providers and products carry unique risks for Black and brown...
TheGrio via Yahoo News· 3 days agoIn many cases, individuals may be unaware that they...weirdly worded reviews, and the cleanliness of...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 2 days agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering ...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Northern Trust Corp
ETF DAILY NEWS· 10 hours agoNorthern Trust Corp reduced its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 6.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,708,357 shares of the medical ...
